Intuitive Surgical delivers 17.12% annualized return over past decade

scanx
Reviewed by
Ritika DScanX News Team
Key Highlights
  • Intuitive Surgical posted a 17.12% annualized return over the last 10 years
  • The stock outperformed the broader market by 3.55% annually during the period
  • Current market capitalization stands at $132.12 billion with a share price of $368.75
  • A $1,000 investment made a decade ago would now be valued at $4,935.75
powered bylight_fuzz_icon
50713013

*this image is generated using AI for illustrative purposes only.

Intuitive Surgical (NASDAQ: ISRG) has delivered an average annual return of 17.12% over the past 10 years. The surgical robotics company has outperformed the broader market by 3.55% on an annualized basis during this period.

As of the time of writing, Intuitive Surgical holds a market capitalization of $132.12 billion. The stock price stood at $368.75.

Investment Growth Analysis

An investor who purchased $1,000 worth of ISRG shares 10 years ago would see that position grow to $4,935.75 today. This calculation is based on the current share price of $368.75.

Metric Value
Annualized Return 17.12%
Market Outperformance 3.55%
Current Market Cap $132.12 billion
Share Price $368.75
10-Year $1k Growth $4,935.75

What the Numbers Show

The data illustrates the impact of compounded returns on long-term capital growth. The divergence between the initial investment ($1,000) and the current value ($4,935.75) highlights how consistent annualized performance accumulates over a decade, resulting in a nearly five-fold increase in nominal value.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

Can Intuitive Surgical sustain its 17% annualized growth rate given its current $132 billion market capitalization and the law of large numbers?

How will emerging competitors in the surgical robotics space, such as Medtronic or Johnson & Johnson, impact ISRG's market share in the next five years?

What role will regulatory approvals for new robotic platforms, like the da Vinci 5, play in driving future revenue streams beyond the installed base?

like18
dislike

Intuitive Surgical says US business decelerating; growth drivers stable

scanx
Reviewed by
Naman SScanX News Team
Key Highlights
  • Intuitive Surgical's U.S. business is currently decelerating
  • The U.S. segment accounts for approximately 60% of total operations
  • Management expects growth drivers to remain consistent in 2026 YoY
powered bylight_fuzz_icon
50504950

*this image is generated using AI for illustrative purposes only.

Intuitive Surgical executive comments indicate the company's U.S. business is decelerating. This segment accounts for approximately 60% of the company's total operations.

The remarks were made during a recent conference call with investors and analysts.

Outlook for 2026

Despite the current deceleration in the U.S. market, management expects the company's growth drivers to remain broadly consistent on a year-over-year basis in 2026.

What the Numbers Show

The U.S. market represents a significant concentration of risk for Intuitive Surgical, contributing roughly 60% of its operational footprint. Any sustained deceleration in this region will have an outsized impact on overall corporate performance compared to other geographies.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What specific strategies is Intuitive Surgical implementing to offset the U.S. deceleration through accelerated international expansion in 2026?

How might the current U.S. slowdown impact the company's capital allocation decisions, such as R&D spending for next-generation robotic platforms?

Are there emerging regulatory or reimbursement hurdles in the U.S. market that could prolong this deceleration beyond the expected 2026 outlook?

like17
dislike

More News on Intuitive Surgical